What is the Cohance Lifesciences Ltd share price today?

The share price of NSE:COHANCE-EQ on 07 Sep 2026 (as of 10:59:04 IST) is ₹448.90.

What is the NSE:COHANCE-EQ 52 week high low price?

Over the past 52 weeks (as of 07 Sep 2026), the NSE:COHANCE-EQ 52 week high low range shows a high of ₹1038.90 and a low of ₹266.70.

What is the Cohance Lifesciences Ltd market cap?

As on 07 Sep 2026, Cohance Lifesciences Ltd market cap is ₹17467.50 Cr.

What is the shareholding pattern of Cohance Lifesciences Ltd Stock?

The shareholding pattern of Cohance Lifesciences Ltd, as of last reported-on 30 Jun 2026 is: Promoters: 57.49% Foreign Institutional Investors (FII): 6.50% Domestic Institutional Investors (DII): 1.88% Mutual Funds: 18.21% Retail & Others: 15.92% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Cohance Lifesciences Ltd?

The Price-to-Earnings (PE) ratio of Cohance Lifesciences Ltd is 164.43, and the Price-to-Book (PB) ratio is 2.97, as on 07 Sep 2026.

Cohance Lifesciences Share Price

454.15-7.30 (-1.58%)

-49.50% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

1 Day

-1.58%

1 Week

+3.69%

1 Month

+1.96%

3 Month

-0.85%

6 Month

+50.03%

YTD

-14.08%

1 Year

-49.50%

5 Year

-16.01%

10 Year

Max

+182.96%

YTD

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

451.10

435.55

416.20

411.00

292.50

266.70

High

464.45

482.25

484.00

514.90

917.85

About

Cohance Lifesciences is a fully integrated global CDMO, partnering with leading innovators across the entire product lifecycle- from route scouting and early development to commercial manufacturing. With advanced capabilities in Read more

Pharmaceuticals & Drugs

Smallcap

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

Name

SUNPHARMANSE

DIVISLABNSE

TORNTPHARMNSE

ZYDUSLIFENSE

CIPLANSE

LAURUSLABSNSE

MANKINDNSE

DRREDDYNSE

AUROPHARMANSE

LUPINNSE

COHANCENSE

LTP

1W Low

1W High

Market cap (₹)

1849.9+12.6 (0.69%)

1832.20

1891.50

4,47,476Cr

9602+227 (2.42%)

9312.50

9740

2,54,764Cr

4928.5+88.5 (1.83%)

4848.50

5010

1,89,423Cr

1180.3+20.3 (1.75%)

1152.10

1190.60

1,16,658Cr

1399+4.5 (0.32%)

1364.50

1419

1,11,484Cr

2026.2+72.2 (3.69%)

1963.80

2055.30

1,09,943Cr

2500+199.3 (8.66%)

2303

2504.30

1,01,712Cr

1200.4+15.4 (1.30%)

1185

1222

1,01,005Cr

1716-18 (-1.04%)

1689.30

1740

99,253Cr

2100.7+17.7 (0.85%)

2080

2135

96,031Cr

454.15+16.15 (3.69%)

435.55

482.25

17,659Cr

Cohance Lifesciences Share Price

454.15-7.30 (-1.58%)

-49.50% past 1 Year

Financial overview

Compounded Sales Growth

10 years-

5 years18%

3 years19%

Last year-13%

Compounded Profit Growth

10 years-

5 years-13%

3 years-24%

Last year-69%

Stock Price CAGR

10 years-

5 years-3%

3 years-5%

1 year-49%

Return on Equity

10 years24%

5 years19%

3 years12%

Last year4%

CAGR%

Sales

Profits

Returns

ROE

10Y	5Y	3Y	TTM
-	18%	19%	-13%
-	-13%	-24%	-69%
-	-3%	-5%	-49%
24%	19%	12%	4%

Peer Comparison

Symbol

SUNPHARMA

DIVISLAB

TORNTPHARM

ZYDUSLIFE

CIPLA

LAURUSLABS

MANKIND

DRREDDY

AUROPHARMA

LUPIN

COHANCE

Price	M.Cap (₹)	PE Ratio	EPS (₹)	EV/EBITDA	Annual PAT
1,849.9	₹447476 Cr	37	12.07	62.82	₹11479 Cr
9,602	₹254764 Cr	87.1	34.04	128.41	₹2568 Cr
4,928.5	₹189423 Cr	86.85	16.72	97.06	₹2163 Cr
1,180.3	₹116658 Cr	25.85	9.42	62.53	₹5040 Cr
1,399	₹111484 Cr	33.08	9.77	57.87	₹3879 Cr
2,026.2	₹109943 Cr	100.55	6.8	29.25	₹889 Cr
2,500	₹101712 Cr	49.79	13.75	71.08	₹1913 Cr
1,200.4	₹101005 Cr	31.35	5.32	63.99	₹4196 Cr
1,716	₹99253 Cr	26.73	17.95	96.84	₹3505 Cr
2,100.7	₹96031 Cr	17.37	30.95	154.35	₹5333 Cr
454.15	₹17659 Cr	166.23	-0.63	7.79	₹179 Cr

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

Balance Sheet

Consolidated

Standalone

₹

Name

Equity And Liabilities

Share Capital

Share Warrants & Outstandings

Total Reserves

Reserve excluding Revaluation Reserve

Shareholder's Funds

Minority Interest

Secured Loans

Unsecured Loans

Deferred Tax Assets / Liabilities

Other Long Term Liabilities

Long Term Provisions

Total Non-Current Liabilities

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Current Liabilities

Total Liabilities

Contingent Liabilities

Total Debt

Assets

Gross Block

Less Accumulated Depreciation

Net Block

Capital Work in Progress

Non Current Investments

Long Term Investment

Long Term Loans & Advances

Other Non Current Assets

Total Non-Current Assets

Current Assets Loans & Advances

Currents Investments

Inventories

Sundry Debtors

Cash and Bank

Other Current Assets

Short Term Loans and Advances

Total Current Assets

Net Current Assets (Including Current Investments)

Total Assets

Book Value

Adjusted Book Value

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
—	—	—	—	—	—	—	—
₹38 Cr	₹25 Cr	₹25 Cr	₹25 Cr	₹25 Cr	₹25 Cr	₹13 Cr	₹0
₹18 Cr	₹82 Cr	₹2 Cr	₹0	₹0	₹0	₹0	₹13 Cr
₹3855 Cr	₹3542 Cr	₹2023 Cr	₹1710 Cr	₹1502 Cr	₹1155 Cr	₹832 Cr	₹578 Cr
₹3855 Cr	₹3542 Cr	₹2023 Cr	₹1710 Cr	₹1502 Cr	₹1155 Cr	₹832 Cr	₹578 Cr
₹3911 Cr	₹3649 Cr	₹2051 Cr	₹1735 Cr	₹1527 Cr	₹1181 Cr	₹845 Cr	₹590 Cr
₹123 Cr	₹144 Cr	₹0	₹0	₹0	₹0	₹0	₹0
₹50 Cr	₹130 Cr	₹0	₹5 Cr	₹28 Cr	₹36 Cr	₹0	₹0
₹0	₹0	₹0	₹0	₹0	₹0	₹91 Cr	₹0
₹95 Cr	₹102 Cr	₹65 Cr	₹58 Cr	₹54 Cr	₹31 Cr	₹28 Cr	₹29 Cr
₹901 Cr	₹750 Cr	₹21 Cr	₹70 L	₹46 L	₹74 L	₹51 L	₹0
₹40 L	₹26 L	₹0	₹8 Cr	₹9 Cr	₹7 Cr	₹8 Cr	₹6 Cr
₹1047 Cr	₹982 Cr	₹86 Cr	₹72 Cr	₹92 Cr	₹74 Cr	₹128 Cr	₹35 Cr
—	—	—	—	—	—	—	—
₹285 Cr	₹268 Cr	₹42 Cr	₹70 Cr	₹106 Cr	₹83 Cr	₹71 Cr	₹54 Cr
₹223 Cr	₹313 Cr	₹21 Cr	₹20 Cr	₹30 Cr	₹29 Cr	₹28 Cr	₹19 Cr
₹74 Cr	₹71 Cr	₹39 Cr	₹65 Cr	₹67 Cr	₹106 Cr	₹94 Cr	₹83 Cr
₹64 Cr	₹53 Cr	₹15 Cr	₹149 Cr	₹145 Cr	₹104 Cr	₹127 Cr	₹35 Cr
₹646 Cr	₹705 Cr	₹117 Cr	₹303 Cr	₹348 Cr	₹322 Cr	₹320 Cr	₹191 Cr
₹5727 Cr	₹5480 Cr	₹2254 Cr	₹2110 Cr	₹1967 Cr	₹1576 Cr	₹1292 Cr	₹816 Cr
₹53 Cr	₹58 Cr	₹18 Cr	₹6 Cr	₹6 Cr	₹6 Cr	₹10 Cr	₹11 Cr
₹170 Cr	₹258 Cr	₹39 Cr	₹69 Cr	₹96 Cr	₹141 Cr	₹185 Cr	₹83 Cr
—	—	—	—	—	—	—	—
₹4231 Cr	₹3788 Cr	₹929 Cr	₹876 Cr	₹694 Cr	₹570 Cr	₹457 Cr	₹347 Cr
₹862 Cr	₹681 Cr	₹260 Cr	₹212 Cr	₹160 Cr	₹128 Cr	₹100 Cr	₹77 Cr
₹3369 Cr	₹3107 Cr	₹670 Cr	₹663 Cr	₹534 Cr	₹441 Cr	₹357 Cr	₹271 Cr
₹173 Cr	₹332 Cr	₹179 Cr	₹165 Cr	₹30 Cr	₹96 Cr	₹102 Cr	₹111 Cr
₹262 Cr	₹145 Cr	₹131 Cr	₹117 Cr	₹117 Cr	₹361 Cr	₹307 Cr	₹7 L
₹262 Cr	₹145 Cr	₹131 Cr	₹117 Cr	₹117 Cr	₹361 Cr	₹307 Cr	₹7 L
₹71 Cr	₹86 Cr	₹22 Cr	₹9 Cr	₹13 Cr	₹11 Cr	₹15 Cr	₹11 Cr
₹19 Cr	₹13 Cr	₹0	₹0	₹7 Cr	₹16 L	₹20 L	₹22 L
₹3899 Cr	₹3687 Cr	₹1001 Cr	₹955 Cr	₹702 Cr	₹910 Cr	₹781 Cr	₹393 Cr
—	—	—	—	—	—	—	—
₹266 Cr	₹192 Cr	₹774 Cr	₹419 Cr	₹481 Cr	₹181 Cr	₹31 Cr	₹7 Cr
₹562 Cr	₹467 Cr	₹231 Cr	₹313 Cr	₹283 Cr	₹201 Cr	₹175 Cr	₹157 Cr
₹681 Cr	₹772 Cr	₹134 Cr	₹111 Cr	₹236 Cr	₹102 Cr	₹117 Cr	₹148 Cr
₹60 Cr	₹102 Cr	₹51 Cr	₹68 Cr	₹47 Cr	₹10 Cr	₹14 Cr	₹13 Cr
₹42 Cr	₹33 Cr	₹12 Cr	₹11 Cr	₹11 Cr	₹12 Cr	₹9 Cr	₹13 Cr
₹185 Cr	₹192 Cr	₹52 Cr	₹233 Cr	₹206 Cr	₹161 Cr	₹165 Cr	₹85 Cr
₹1796 Cr	₹1758 Cr	₹1253 Cr	₹1155 Cr	₹1265 Cr	₹667 Cr	₹511 Cr	₹423 Cr
₹1150 Cr	₹1053 Cr	₹1136 Cr	₹852 Cr	₹918 Cr	₹345 Cr	₹191 Cr	₹232 Cr
₹5727 Cr	₹5480 Cr	₹2254 Cr	₹2110 Cr	₹1967 Cr	₹1576 Cr	₹1292 Cr	₹816 Cr
₹102	₹140	₹80	₹68	₹60	₹46	₹66	₹0
₹102	₹140	₹80	₹68	₹60	₹46	₹33	₹0

Cash Flow

Consolidated

Standalone

₹

Name

Profit Before Tax

Adjustment

Changes In working Capital

Cash Flow after changes in Working Capital

Cash Flow from Operating Activities

Cash Flow from Investing Activities

Cash Flow from Financing Activitie

Net Cash Inflow / Outflow

Opening Cash & Cash Equivalents

Effect of Foreign Exchange Fluctuations

Closing Cash & Cash Equivalent

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
₹207 Cr	₹643 Cr	₹406 Cr	₹560 Cr	₹668 Cr	₹468 Cr	₹405 Cr	₹158 Cr
₹208 Cr	₹207 Cr	₹17 Cr	₹37 Cr	₹41 Cr	₹36 Cr	₹35 Cr	₹14 Cr
₹21 Cr	-₹73 L	₹72 Cr	₹6 Cr	-₹194 Cr	-₹12 Cr	₹54 Cr	-₹88 Cr
₹436 Cr	₹849 Cr	₹495 Cr	₹603 Cr	₹514 Cr	₹492 Cr	₹493 Cr	₹83 Cr
₹368 Cr	₹673 Cr	₹385 Cr	₹457 Cr	₹330 Cr	₹383 Cr	₹407 Cr	₹50 Cr
-₹255 Cr	-₹390 Cr	-₹362 Cr	-₹195 Cr	-₹136 Cr	-₹311 Cr	-₹413 Cr	-₹65 Cr
-₹165 Cr	-₹327 Cr	-₹40 Cr	-₹242 Cr	-₹156 Cr	-₹76 Cr	₹7 Cr	₹26 Cr
-₹51 Cr	-₹44 Cr	-₹18 Cr	₹20 Cr	₹37 Cr	-₹5 Cr	₹79 L	₹11 Cr
₹97 Cr	₹138 Cr	₹65 Cr	₹45 Cr	₹7 Cr	₹12 Cr	₹11 Cr	₹0
₹4 Cr	₹2 Cr	₹0	₹0	₹4,000	₹3,000	₹6,000	₹0
₹49 Cr	₹97 Cr	₹47 Cr	₹65 Cr	₹45 Cr	₹7 Cr	₹12 Cr	₹11 Cr

Fundamental Ratios

Consolidated

Standalone

Cohance Lifesciences Share Price

454.15-7.30 (-1.58%)

-49.50% past 1 Year

Shareholding summary

Promoters

57.49%

FII

6.5%

DII

1.88%

18.21%

Others

15.92%

Promoters

FII

DII

Others

Quarterly

Yearly

Shareholding Pattern

Quarterly

Yearly

Name

Promoters

FII

DII - Others

DII - MFs

Retail & Others

Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
57.49%	57.49%	57.49%	57.49%	66.41%	50.10%
6.50%	5.59%	6.01%	6.51%	7.23%	11.05%
1.88%	3.22%	4.21%	4.32%	2.50%	3.56%
18.21%	18.57%	17.36%	16.49%	8.90%	13.04%
15.92%	15.13%	14.93%	15.19%	14.96%	22.25%

Bulk & block deals

Name

Jasub Property Holdings Llp

Jasti Family Trust

Jasub Property Holdings Llp

Jasti Family Trust

Jasub Property Holdings Llp

Jasti Family Trust

Jasub Property Holdings Llp

Jasti Family Trust

Bnp Paribas Financial Markets

Morgan Stanley Asia (Singapore) Pte.

Deal Date	Action	Deal Value	Deal Price	Qty Traded	Deal Type	%Stake Traded	Exchange
23 Feb 2026	Purchase	235.62 Cr	₹306	77 L	Bulk	2.01256	NSE
23 Feb 2026	Sell	235.62 Cr	₹306	77 L	Bulk	2.01256	NSE
23 Feb 2026	Purchase	235.62 Cr	₹306	77 L	Block	2.01256	NSE
23 Feb 2026	Sell	235.62 Cr	₹306	77 L	Block	2.01256	NSE
18 Feb 2026	Purchase	216.30 Cr	₹309	70 L	Bulk	1.8296	NSE
18 Feb 2026	Sell	216.30 Cr	₹309	70 L	Bulk	1.8296	NSE
18 Feb 2026	Purchase	216.30 Cr	₹309	70 L	Block	1.8296	NSE
18 Feb 2026	Sell	216.30 Cr	₹309	70 L	Block	1.8296	NSE
23 Oct 2025	Purchase	10.02 Cr	₹890.75	1.12 L	Block	0.029402	BSE
23 Oct 2025	Sell	10.02 Cr	₹890.75	1.12 L	Block	0.029402	BSE

Insider trading & SAST

Client name

Dsp Trustee Pvt Ltd

Jusmiral Holdings Limited

Jasti Property & Equity Holdings Pvt Ltd & Others

Jasub Property Holdings Llp & Pacs

Jusmiral Holdings Ltd & Pacs

Jusmiral Holdings Limited

Dr. Venkata Naga Kali Vara Prasada Raju Vetukuri

Reported on	Client category	Action	%Stake traded	Holding % post deal	Deal value	Deal price	Qty traded	Deal period	Deal mode	Post transaction holding	Insider/SAST	Regulation type	Security type
25 Aug 2026	Other	Disposal	0.76	3.53	0	—	29 L	07 Aug 2026	Market	1,34,97,073	SAST	29(2)	—
09 Jul 2026	Promoter	Others	—	—	0	—	8.04 Cr	17 Jun 2026	Creation	8,04,34,990	SAST	Reg31	—
30 Jun 2026	Promoter	Others	—	—	0	—	9.24 Cr	16 Jun 2026	Release	0	SAST	Reg31	—
12 Mar 2026	Other	Disposal	2.01	6.36	0	—	77 L	23 Feb 2026	Inter-se Transfer	2,43,26,009	SAST	29(2)	—
09 Mar 2026	Other	Disposal	2.06	4.53	0	—	78.77 L	18 Feb 2026	Market	1,73,16,009	SAST	29(2)	—
09 Mar 2026	Other	Acquisition	1.83	1.83	0	—	70 L	18 Feb 2026	Inter-se Transfer	70,00,000	SAST	29(1)	—
01 Oct 2025	Promoter	Disposal	8.93	57.49	0	—	3.41 Cr	18 Sep 2025	Market	21,99,30,170	SAST	29(2)	—
23 Sep 2025	Promoter	Others	—	—	0	—	3.41 Cr	18 Sep 2025	Release	9,23,90,578	SAST	Reg31	—
19 Sep 2025	Promoter	Disposal	8.926016	24.15	3,093.81 Cr	₹906	3.41 Cr	18 Sep 2025	Market Sale	9,23,90,578	Insider Trading	—	Equity Shares
28 Aug 2025	Director	Disposal	0.156835	0.03	52.82 Cr	₹880.30	6 L	26 Aug 2025	Market Sale	1,13,259	Insider Trading	—	Equity Shares